KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Inventory Average: 2009-2025

Historic Inventory Average for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Sep 2025 value amounting to $1.4 billion.

  • Biomarin Pharmaceutical's Inventory Average rose 15.21% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 15.21%. This contributed to the annual value of $1.2 billion for FY2024, which is 16.92% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Inventory Average stood at $1.4 billion for Q3 2025, which was up 4.10% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Biomarin Pharmaceutical's Inventory Average peaked at $1.4 billion during Q3 2025, and registered a low of $706.2 million during Q1 2021.
  • Over the past 3 years, Biomarin Pharmaceutical's median Inventory Average value was $1.2 billion (recorded in 2024), while the average stood at $1.1 billion.
  • Its Inventory Average has fluctuated over the past 5 years, first decreased by 1.70% in 2021, then climbed by 23.84% in 2024.
  • Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Inventory Average stood at $763.0 million in 2021, then grew by 13.59% to $866.8 million in 2022, then increased by 23.41% to $1.1 billion in 2023, then rose by 12.74% to $1.2 billion in 2024, then rose by 15.21% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.